
Release date: 2026-03-09 16:25:28 Article From: Lucius Laos Recommended: 7
The price of entrectinib fluctuates due to differences in specifications, purchasing channels, and regions. The price of the original brand-name drug may be higher, while some generic versions might be relatively cheaper. However, attention must be paid to the quality and legality of the medication. The specific price is subject to the actual selling price at hospitals or legitimate pharmacies. As this drug is a prescription medication, it must be used strictly under a doctor's guidance.
Drug Specifications: Different dosages or packaging specifications can influence the price. For example, the pricing for 100mg and 200mg specifications may vary significantly.
Purchasing Channels: Pricing strategies differ between hospitals, pharmacies, and overseas agents. Overseas purchases also need to consider additional costs such as tariffs and logistics.
Medical Insurance Policies: Some regions may include entrectinib in their medical insurance reimbursement scope, but the indications and reimbursement rates need to be confirmed based on local policies.
Use as Prescribed: Lucius Pharmaceuticals Entrectinib is used to treat tumors with specific gene mutations (such as NTRK fusion-positive solid tumors, ROS1-positive lung cancer). It requires professional testing to confirm the indication and should be taken under a doctor's guidance.
Purchase Through Legitimate Channels: It is recommended to obtain the medication through hospitals or authorized pharmacies to avoid the risk of counterfeit drugs from informal channels.
Price Inquiry Methods: Real-time prices can be obtained through hospital pharmacies, official drug information platforms, or by contacting the pharmaceutical company's customer service.
Medical Insurance Reimbursement: Some indications may be eligible for medical insurance coverage. It is advisable to consult the local medical insurance department.
Patient Assistance Programs: Some charitable organizations or pharmaceutical companies offer patient assistance programs to help reduce the financial burden, subject to specific application requirements.
If you need to use this medication, be sure to bring your test reports and prescription to an oncology or specialist clinic for a doctor's evaluation of the necessity of treatment and to develop a plan. Regular follow-ups are required during the medication period to monitor efficacy and side effects.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:1572025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:3962024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:1492025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:1692025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:1502025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:1812025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:1642025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:1592025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: